<DOC>
	<DOCNO>NCT01580306</DOCNO>
	<brief_summary>The main objective study investigate influence mild , moderate severe renal impairment pharmacokinetics safety BI 201335 comparison control group normal renal function single dose BI 201335 .</brief_summary>
	<brief_title>Pharmacokinetics Safety BI 201335 Patients With Mild Severe Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Inclusion criterion : Male female healthy subject normal renal function subject impair renal function relatively good health Exclusion criterion : Any relevant deviation healthy condition healthy volunteer significant disease renal impairment renal impaired subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>